跳至主要内容
临床试验/NCT04062136
NCT04062136已完成1 期

Outcomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Transplantation in the Treatment of Bronchopulmonary Dysplasia

Vinmec Research Institute of Stem Cell and Gene Technology2 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2019年3月1日最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
入组人数
10
试验地点
2
主要终点
Adverse events and serious adverse events

研究概览

简要总结

To evaluate the safety and efficacy of human umbilical cord mesenchymal stem cells transplantation in patients with bronchopulmonary dysplasia

详细描述

The purpose of this study is to evaluate the safety and effectiveness of human umbilical cord mesenchymal stem cells in 10 patients with bronchopulmonary dysplasia at Vinmec International Hospital, Hanoi, Vietnam

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Month 至 6 Months(Child)
性别
All
接受健康志愿者

入选标准

  • The patient is diagnosis Bronchopulmonary Dysplasia (premature and depends on oxygen until 28 days old
  • Gender: either sex
  • Year old < 6 months
  • Weight ≥ 2 kg
  • Agree to participate in the study.

排除标准

  • Severe congenital malformation.
  • Other severe conditions (active pulmonary bleeding, evidence of active infections).

结局指标

主要结局

Adverse events and serious adverse events

时间窗: during 9 months post treatment

Incidence of the adverse events or serious adverse events after transplantation

The proportion of patients win from oxygen

时间窗: during 9 months post treatment

To identify the proportion of patient with Bronchopulmonary Dysplasia win from oxygen after stem cell transplantation.

次要结局

  • The lung fibrosis(at 6 months post treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验